News

Orgenesis Inc. announced that its subsidiary, Masthercell Global Inc., is expanding into the United States and has executed a lease agreement to build a new 30,000 sq. ft manufacturing…
Read More...

Olon S.p.A. announced the acquisition of Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation, as part of a continuing expansion of its…
Read More...

Concert Pharmaceuticals announced that it has initiated the second Phase 1 clinical trial with CTP-692, a novel deuterium-modified form of D-serine being developed as an adjunctive…
Read More...

ArQule, Inc.’s partner, Basilea Pharmaceutica announced that it entered into a collaboration with Roche to explore a combination of derazantinib (BAL087) and Roche’s PD-L1-blocking…
Read More...

Following the recent U.S Food and Drug Administration (FDA) approval of the Prior Approval Supplement (PAS) for second-generation Andexxa, Portola Pharmaceuticals, Inc. and Lonza…
Read More...

Ferring Pharmaceuticals (U.S.) announced that it has appointed Sophie Opdyke, Pharm.D., MBA as Vice President, General Manager, Oncology, effective immediately. She most recently served…
Read More...

Ironwood Pharmaceuticals announced the initiation of a Phase 1 study evaluating IW-6463 in healthy volunteers. IW-6463 is an orally administered central nervous system (CNS)-penetrant…
Read More...

Rigel Pharmaceuticals announced that it has entered into an exclusive license and supply agreement with Spain-based Grifols to commercialize fostamatinib disodium hexahydrate in all…
Read More...

CAMP4 Therapeutics announced a research collaboration with Alnylam Pharmaceuticals focused on identifying new druggable targets to address an undisclosed rare disease of the liver with…
Read More...

B-MoGen Biotechnologies and CytoSen Therapeutics announced a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies. B-MoGen will…
Read More...

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, and MAB…
Read More...

PeptiDream announced that it has entered into a multi-program collaborative research agreement with Osaka-based Shionogi & Co., Ltd for the discovery and development of a series of…
Read More...

Philogen announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

Incyte Corporation announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the first-line treatment of patients with chronic graft-versus-host…
Read More...

Alvotech announced that it has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance…
Read More...

Ferring Pharmaceuticals and Karolinska Institutet announced a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and…
Read More...

Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and software to manage the collection and…
Read More...

GlaxoSmithKline plc announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash…
Read More...

Vertex Pharmaceuticals (Europe) Limited announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatment of…
Read More...

Alnylam Pharmaceuticals and Medison Pharma announced an exclusive agreement to commercialize ONPATTRO, the first-ever commercialized RNAi therapeutic, as well as other investigational…
Read More...